Phase IIb trial of leucine/metformin in patients with type 2 diabetes mellitus

Trial Profile

Phase IIb trial of leucine/metformin in patients with type 2 diabetes mellitus

Planning
Phase of Trial: Phase II

Latest Information Update: 15 Oct 2014

At a glance

  • Drugs Leucine/metformin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors NuSirt Biopharma
  • Most Recent Events

    • 15 Oct 2014 New trial record
    • 20 Aug 2014 This trial will be initiated if the phase IIa trial (see profile 245735) is successful, according to a NuSirt Biopharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top